vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Research Solutions, Inc. (RSSS). Click either name above to swap in a different company.

Research Solutions, Inc. is the larger business by last-quarter revenue ($11.8M vs $8.1M, roughly 1.5× Arcellx, Inc.). Research Solutions, Inc. runs the higher net margin — 4.6% vs -766.0%, a 770.7% gap on every dollar of revenue. On growth, Research Solutions, Inc. posted the faster year-over-year revenue change (-1.0% vs -79.3%). Research Solutions, Inc. produced more free cash flow last quarter ($1.4M vs $-63.9M). Over the past eight quarters, Research Solutions, Inc.'s revenue compounded faster (-1.3% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Jacobs Solutions Inc. is an American international technical professional services firm based in Dallas. The company provides engineering, technical, professional, and construction services as well as scientific and specialty consulting for a broad range of clients globally, including companies, organizations, and government agencies. Jacobs has consistently ranked No. 1 on both Engineering News-Record (ENR)'s 2018, 2019, 2020, 2021, 2022, and 2023 Top 500 Design Firms and Trenchless Technolo...

ACLX vs RSSS — Head-to-Head

Bigger by revenue
RSSS
RSSS
1.5× larger
RSSS
$11.8M
$8.1M
ACLX
Growing faster (revenue YoY)
RSSS
RSSS
+78.3% gap
RSSS
-1.0%
-79.3%
ACLX
Higher net margin
RSSS
RSSS
770.7% more per $
RSSS
4.6%
-766.0%
ACLX
More free cash flow
RSSS
RSSS
$65.3M more FCF
RSSS
$1.4M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
RSSS
RSSS
Annualised
RSSS
-1.3%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q2 FY2026

Metric
ACLX
ACLX
RSSS
RSSS
Revenue
$8.1M
$11.8M
Net Profit
$-62.3M
$546.9K
Gross Margin
52.4%
Operating Margin
-847.6%
6.3%
Net Margin
-766.0%
4.6%
Revenue YoY
-79.3%
-1.0%
Net Profit YoY
-765.1%
127.6%
EPS (diluted)
$-1.13
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
RSSS
RSSS
Q4 25
$11.8M
Q3 25
$12.3M
Q2 25
$12.4M
Q1 25
$8.1M
$12.7M
Q4 24
$15.3M
$11.9M
Q3 24
$26.0M
$12.0M
Q2 24
$27.4M
$12.1M
Q1 24
$39.3M
$12.1M
Net Profit
ACLX
ACLX
RSSS
RSSS
Q4 25
$546.9K
Q3 25
$749.4K
Q2 25
$2.4M
Q1 25
$-62.3M
$216.5K
Q4 24
$-47.1M
$-2.0M
Q3 24
$-25.9M
$669.0K
Q2 24
$-27.2M
$-2.8M
Q1 24
$-7.2M
$76.3K
Gross Margin
ACLX
ACLX
RSSS
RSSS
Q4 25
52.4%
Q3 25
50.6%
Q2 25
51.0%
Q1 25
49.5%
Q4 24
48.9%
Q3 24
47.9%
Q2 24
46.5%
Q1 24
45.2%
Operating Margin
ACLX
ACLX
RSSS
RSSS
Q4 25
6.3%
Q3 25
7.8%
Q2 25
9.7%
Q1 25
-847.6%
4.4%
Q4 24
-348.2%
0.8%
Q3 24
-129.1%
5.4%
Q2 24
-127.8%
5.5%
Q1 24
-40.3%
0.7%
Net Margin
ACLX
ACLX
RSSS
RSSS
Q4 25
4.6%
Q3 25
6.1%
Q2 25
19.0%
Q1 25
-766.0%
1.7%
Q4 24
-308.4%
-16.6%
Q3 24
-99.4%
5.6%
Q2 24
-99.3%
-23.3%
Q1 24
-18.3%
0.6%
EPS (diluted)
ACLX
ACLX
RSSS
RSSS
Q4 25
$0.02
Q3 25
$0.02
Q2 25
$0.08
Q1 25
$-1.13
$0.01
Q4 24
$-0.87
$-0.07
Q3 24
$-0.48
$0.02
Q2 24
$-0.51
$-0.09
Q1 24
$-0.14
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
RSSS
RSSS
Cash + ST InvestmentsLiquidity on hand
$543.3M
$12.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$416.9M
$17.2M
Total Assets
$648.1M
$44.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
RSSS
RSSS
Q4 25
$12.3M
Q3 25
$12.0M
Q2 25
$12.2M
Q1 25
$543.3M
$9.9M
Q4 24
$587.4M
$7.7M
Q3 24
$574.3M
$6.9M
Q2 24
$516.7M
$6.1M
Q1 24
$573.9M
$4.2M
Stockholders' Equity
ACLX
ACLX
RSSS
RSSS
Q4 25
$17.2M
Q3 25
$15.6M
Q2 25
$13.9M
Q1 25
$416.9M
$11.2M
Q4 24
$454.8M
$11.1M
Q3 24
$483.0M
$12.8M
Q2 24
$487.2M
$11.7M
Q1 24
$496.6M
$14.1M
Total Assets
ACLX
ACLX
RSSS
RSSS
Q4 25
$44.2M
Q3 25
$45.5M
Q2 25
$46.1M
Q1 25
$648.1M
$45.2M
Q4 24
$711.3M
$42.8M
Q3 24
$764.9M
$41.4M
Q2 24
$734.3M
$41.9M
Q1 24
$779.7M
$40.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
RSSS
RSSS
Operating Cash FlowLast quarter
$-63.1M
$1.4M
Free Cash FlowOCF − Capex
$-63.9M
$1.4M
FCF MarginFCF / Revenue
-786.4%
11.7%
Capex IntensityCapex / Revenue
9.6%
0.1%
Cash ConversionOCF / Net Profit
2.53×
TTM Free Cash FlowTrailing 4 quarters
$-122.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
RSSS
RSSS
Q4 25
$1.4M
Q3 25
$1.1M
Q2 25
$2.3M
Q1 25
$-63.1M
$2.9M
Q4 24
$-46.0M
$1.0M
Q3 24
$30.7M
$843.1K
Q2 24
$-36.2M
$2.0M
Q1 24
$-31.9M
$2.0M
Free Cash Flow
ACLX
ACLX
RSSS
RSSS
Q4 25
$1.4M
Q3 25
$1.1M
Q2 25
Q1 25
$-63.9M
$2.9M
Q4 24
$-47.5M
Q3 24
$28.4M
Q2 24
$-39.5M
$1.9M
Q1 24
$-38.3M
$2.0M
FCF Margin
ACLX
ACLX
RSSS
RSSS
Q4 25
11.7%
Q3 25
8.8%
Q2 25
Q1 25
-786.4%
22.8%
Q4 24
-311.3%
Q3 24
109.2%
Q2 24
-144.1%
16.0%
Q1 24
-97.7%
16.6%
Capex Intensity
ACLX
ACLX
RSSS
RSSS
Q4 25
0.1%
Q3 25
0.1%
Q2 25
Q1 25
9.6%
0.0%
Q4 24
9.8%
Q3 24
8.8%
Q2 24
11.7%
0.1%
Q1 24
16.4%
0.0%
Cash Conversion
ACLX
ACLX
RSSS
RSSS
Q4 25
2.53×
Q3 25
1.48×
Q2 25
0.96×
Q1 25
13.36×
Q4 24
Q3 24
1.26×
Q2 24
Q1 24
26.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

RSSS
RSSS

Transactions$6.6M56%
Platforms$5.2M44%

Related Comparisons